Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis

(2009) Chun Geun Lee et al.   JOURNAL OF EXPERIMENTAL MEDICINE

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

(2009) R Shao et al.   ONCOGENE

Serum YKL-40 as a marker for cervical adenocarcinoma

(2008) A. Mitsuhashi et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Diurnal, Weekly, and Long-Time Variation in Serum Concentrations of YKL-40 in Healthy Subjects

(2008) J. S. Johansen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients

(2008) Anne K. Mylin et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Elevated Plasma YKL-40 Predicts Increased Risk of Gastrointestinal Cancer and Decreased Survival After Any Cancer Diagnosis in the General Population

(2008) Julia S. Johansen et al.   JOURNAL OF CLINICAL ONCOLOGY